...
search icon
prme-img

Prime Medicine, Inc. Common Stock, Common Stock

PRME

NMQ

$1.175

-$0.16

(-11.99%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$175.93M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
7.85M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.90
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.11 L
$8.14 H
$1.175

About Prime Medicine, Inc. Common Stock, Common Stock

Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and pegRNA which contains a search sequence, also known as a spacer, which provides a target genomic address for the Prime Editor. The company has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. Prime Medicine, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FramePRMESectorS&P500
1-Week Return-7.48%1.9%1.37%
1-Month Return-15.47%1.36%15.76%
3-Month Return-62.46%-8.73%-2.58%
6-Month Return-60.7%-5.96%0.72%
1-Year Return-84.4%-7.97%12.24%
3-Year Return-92.36%3.54%52.73%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue5.21M-5.21M-2.98M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":57.26,"profit":true}]
Cost of Revenue2.98K4.86M12.01M147.91M6.13M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":3.29,"profit":true},{"date":"2022-12-31","value":8.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":4.14,"profit":true}]
Gross Profit5.21M(4.86M)(6.80M)(147.91M)(3.15M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-93.35,"profit":false},{"date":"2022-12-31","value":-130.67,"profit":false},{"date":"2023-12-31","value":-2840.49,"profit":false},{"date":"2024-12-31","value":-60.4,"profit":false}]
Gross Margin99.94%-(130.60%)-(105.43%)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-130.67,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-105.49,"profit":false}]
Operating Expenses6.14M84.47M116.54M186.64M205.45M[{"date":"2020-12-31","value":2.99,"profit":true},{"date":"2021-12-31","value":41.12,"profit":true},{"date":"2022-12-31","value":56.73,"profit":true},{"date":"2023-12-31","value":90.84,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(932.00K)(84.47M)(116.54M)(191.29M)(202.47M)[{"date":"2020-12-31","value":-93200000,"profit":false},{"date":"2021-12-31","value":-8447400000,"profit":false},{"date":"2022-12-31","value":-11654400000,"profit":false},{"date":"2023-12-31","value":-19129200000,"profit":false},{"date":"2024-12-31","value":-20246700000,"profit":false}]
Total Non-Operating Income/Expense---(4.31M)10.11M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-42.63,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(1.54M)(165.85M)(122.77M)(198.41M)(195.88M)[{"date":"2020-12-31","value":-154300000,"profit":false},{"date":"2021-12-31","value":-16585300000,"profit":false},{"date":"2022-12-31","value":-12276900000,"profit":false},{"date":"2023-12-31","value":-19841200000,"profit":false},{"date":"2024-12-31","value":-19588200000,"profit":false}]
Income Taxes1.87M(486.00K)(948.00K)(279.00K)-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-26.03,"profit":false},{"date":"2022-12-31","value":-50.78,"profit":false},{"date":"2023-12-31","value":-14.94,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes---(198.13M)-[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-19813300000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(3.41M)(165.37M)(121.82M)(171.77M)(195.88M)[{"date":"2020-12-31","value":-341000000,"profit":false},{"date":"2021-12-31","value":-16536700000,"profit":false},{"date":"2022-12-31","value":-12182100000,"profit":false},{"date":"2023-12-31","value":-17177300000,"profit":false},{"date":"2024-12-31","value":-19588200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(3.41M)(165.37M)(121.82M)(198.13M)(195.88M)[{"date":"2020-12-31","value":-341000000,"profit":false},{"date":"2021-12-31","value":-16536700000,"profit":false},{"date":"2022-12-31","value":-12182100000,"profit":false},{"date":"2023-12-31","value":-19813300000,"profit":false},{"date":"2024-12-31","value":-19588200000,"profit":false}]
EPS (Diluted)--(1.85)(2.18)(1.65)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-185,"profit":false},{"date":"2023-12-31","value":-218,"profit":false},{"date":"2024-12-31","value":-165,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PRME
Cash Ratio 4.21
Current Ratio 4.78

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PRME
ROA (LTM) -40.36%
ROE (LTM) -115.21%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PRME
Debt Ratio Lower is generally better. Negative is bad. 0.67
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.33

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PRME
Trailing PE NM
Forward PE NM
P/S (TTM) 45.57
P/B 1.64
Price/FCF NM
EV/R 39.57
EV/Ebitda NM

FAQs

What is Prime Medicine, Inc. Common Stock share price today?

Prime Medicine, Inc. Common Stock (PRME) share price today is $1.175

Can Indians buy Prime Medicine, Inc. Common Stock shares?

Yes, Indians can buy shares of Prime Medicine, Inc. Common Stock (PRME) on Vested. To buy Prime Medicine, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PRME stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Prime Medicine, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Prime Medicine, Inc. Common Stock (PRME) via the Vested app. You can start investing in Prime Medicine, Inc. Common Stock (PRME) with a minimum investment of $1.

How to invest in Prime Medicine, Inc. Common Stock shares from India?

You can invest in shares of Prime Medicine, Inc. Common Stock (PRME) via Vested in three simple steps:

  • Click on Sign Up or Invest in PRME stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Prime Medicine, Inc. Common Stock shares
What is Prime Medicine, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Prime Medicine, Inc. Common Stock (PRME) is $8.14. The 52-week low price of Prime Medicine, Inc. Common Stock (PRME) is $1.11.

What is Prime Medicine, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Prime Medicine, Inc. Common Stock (PRME) is 1.64

What is the Market Cap of Prime Medicine, Inc. Common Stock?

The market capitalization of Prime Medicine, Inc. Common Stock (PRME) is $175.93M

What is Prime Medicine, Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of Prime Medicine, Inc. Common Stock is PRME

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top